# Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month Study

> **NCT01220817** · PHASE2 · COMPLETED · sponsor: **POM Wonderful LLC** · enrollment: 104 (actual)

## Conditions studied

- Recurrent Prostate Cancer

## Interventions

- **DRUG:** 3 POMx capsules
- **DRUG:** 1 POMx capsule

## Key facts

- **NCT ID:** NCT01220817
- **Lead sponsor:** POM Wonderful LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2012-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220817, "Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01220817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*